Hetlioz Approval History
FDA Approved: Yes (First approved January 31, 2014)
Brand name: Hetlioz
Generic name: tasimelteon
Dosage form: Capsules
Company: Vanda Pharmaceuticals Inc.
Treatment for: Non-24-Hour Disorder
Hetlioz (tasimelteon) is a melatonin receptor agonist for the treatment of Non-24-Hour Disorder in the totally blind.
Development History and FDA Approval Process for Hetlioz
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.